pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
REGENERON PHARMACEUTICALS · news · pharmadog
← back to REGENERON PHARMACEUTICALS
News mentioning REGENERON PHARMACEUTICALS
43
stories
3d
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
biopharma dive
4d
Pfizer’s eczema drug clears skin in mid-stage trial
biopharma dive
4d
Sanofi pays Regeneron $1B upfront to continue search for Dupixent successor
biospace
4d
STAT+: Sanofi, Regeneron expand partnership after Dupixent success
stat
4d
Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D
fiercebiotech
4d
The top 12 companies hiring in biopharma now
biospace
5d
PhRMA names next CEO; Pierre Fabre takes third swing at Ebvallo approval
biopharma dive
7d
Kodiak skyrockets on positive study data for 2 eye drugs
biopharma dive
7d
FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
biospace
7d
6 immunology targets to sustain a mammoth I&I market
biospace
12d
9 companies hiring in Pennsylvania now
biospace
18d
Trending: Top biopharma disciplines with jobs live now
biospace
18d
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
Aug 28, 26
AstraZeneca, Amgen poised to challenge Dupixent’s reign with esophagitis win
biospace
Aug 20, 26
Regeneron to challenge Ipsen as FDA clears bone disease drug
biopharma dive
Aug 20, 26
STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
stat
Aug 19, 26
STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval
stat
Aug 19, 26
11 companies hiring in New Jersey
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 18, 26
Regeneron ends eye disease study due to antibody's safety profile
biospace
Aug 17, 26
EyePoint plummets on pivotal data for main drug
biopharma dive
Aug 17, 26
EyePoint’s Phase 3 fail sends stock spiraling amid next-gen AMD race
biospace
Aug 17, 26
Regeneron ends eye disease trial for anti-CD3 antibody following safety review
fiercebiotech
Aug 12, 26
7 companies hiring in North Carolina now
biospace
Aug 10, 26
Regeneron backs $75M series A for antibody upstart Infinimmune
fiercebiotech
Aug 5, 26
A COPD drug from China draws $115M in venture funding
biopharma dive
Jul 31, 26
Sanofi to ‘rebuild trust’ with Regeneron; Apnimed adds to string of ‘upsized’ biotech IPOs
biopharma dive
Jul 30, 26
Regeneron’s ‘aversion’ to M&A questioned as bumper Q2 builds war chest
biospace
Jul 29, 26
7 companies hiring in New York now
biospace
Jul 22, 26
6 companies hiring in Cambridge now
biospace
← prev
page 1 of 2
next →
